GLP-1 Market
LLY $1373.70 ▲ +6.6% NVO $39.14 ▲ +2.2% PFE $29.95 ▲ +1.7% VKTX $26.86 ▲ +5.9% KLRA $13.41 ▼ -0.1% GPCR $21.94 ▲ +2.1% RHHBY $60.77 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Glucocorticoid treatment

Company
Prof Dr Frank Buttgereit
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 30, 2026

Find a Clinical Trial Near Me

See recruiting studies for Glucocorticoid treatment and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02719314

    Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis

    Prof Dr Frank Buttgereit 10000 participants Est. completion 2032-12 1 site
    Other conditions: Osteoporosis, Inflammatory Rheumatism
    View official trial listing →
  • Recruiting NCT NCT03153527

    Taper Or Abrupt Steroid Stop: TOASSTtrial

    Not yet reported University Hospital, Basel, Switzerland 530 participants Est. completion 2027-06 16 sites
    Other conditions: Inflammatory Disorder, Autoimmune
    View official trial listing →
  • Recruiting NCT NCT03760835

    Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

    Not yet reported Federico II University 150 participants Est. completion 2027-12-31 1 site
    Other conditions: Congenital Adrenal Hyperplasia
    View official trial listing →
  • Recruiting NCT NCT05193396

    Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

    Not yet reported Marianne Andersen 100 participants Est. completion 2026-01 3 sites
    Other conditions: Adrenal Insufficiency, Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)
    View official trial listing →
  • Recruiting NCT NCT06395883

    Dynamics in Bone Turnover Markers During and After Short-term Glucocorticoid Treatment in Patients With an Inflammatory Joint Disease

    Diakonhjemmet Hospital 160 participants Est. completion 2028-12 2 sites
    Other conditions: Osteoporosis, Osteoporosis, Steroid Induced, Inflammatory Rheumatism
    View official trial listing →
  • Recruiting NCT NCT07152366

    Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

    Not yet reported Shanghai Changzheng Hospital 96 participants Est. completion 2035-04-15 1 site
    Other conditions: Thyroid Associated Ophthalmopathies
    View official trial listing →
  • Completed NCT NCT00204737

    Short Course Glucocorticoid Treatment for PTSD

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2009-01 2 sites
    Other conditions: Post-traumatic Stress Disorder
    View official trial listing →
  • Terminated NCT NCT00572299

    Glucocorticoids Promote Osteoclast Survival

    University of Arkansas 3 participants Est. completion 2010-05 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00773058

    Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)

    Not yet reported Southeast University, China 100 participants
    Other conditions: Acute Respiratory Distress Syndrome, Adrenal Insufficiency
    View official trial listing →
  • Completed NCT NCT00972530

    Intra-articular Glucocorticoid Treatment of the Elbow

    Not yet reported Region Gävleborg 90 participants Est. completion 2008-12
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00975078

    Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment

    Not yet reported University Hospital, Basel, Switzerland 39 participants Est. completion 2009-10 1 site
    Other conditions: Adrenal Gland Hypofunction
    View official trial listing →
  • Completed NCT NCT01063569

    Glucocorticoid Treatment in Addison's Disease

    Not yet reported, Not yet reported Haukeland University Hospital 33 participants Est. completion 2012-12 3 sites
    Other conditions: Addison's Disease
    View official trial listing →
  • Terminated NCT NCT01574014

    Glucocorticoid Treatment for Social Phobia

    Not yet reported Insel Gruppe AG, University Hospital Bern 66 participants Est. completion 2012-04 1 site
    Other conditions: Phobic Disorders, Phobias
    View official trial listing →
  • Status unknown NCT NCT01627236

    Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Severe Acute Exacerbation of Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT01714427

    Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid Treatment

    Not yet reported Medical University of Vienna 36 participants Est. completion 2012-06 1 site
    Other conditions: Experimental Lung Inflammation
    View official trial listing →
  • Completed NCT NCT02253121

    Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Not yet reported Slotervaart Hospital 46 participants Est. completion 2017-05 4 sites
    Other conditions: Hyperglycemia Steroid-induced
    View official trial listing →
  • Status unknown NCT NCT02872584

    Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids

    Rambam Health Care Campus 20 participants Est. completion 2018-09
    Other conditions: Glucocorticoid
    View official trial listing →
  • Completed NCT NCT03018600

    Continuous Glucose Monitoring on Patients With Active Autoimmune Diseases Following High-dose Predisone Treatment

    Peking Union Medical College Hospital 25 participants Est. completion 2016-09
    Other conditions: Glucocorticoid-induced Hyperglycemia
    View official trial listing →
  • Completed NCT NCT03136562

    Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients in Glucocorticoid Treatment

    Copenhagen University Hospital, Rigshospitalet 60 participants Est. completion 2019-06-01 1 site
    Other conditions: Adrenal Insufficiency
    View official trial listing →
  • Completed NCT NCT03140761

    The Prevalence of Secondary Adrenal Insufficiency in Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene

    Chronic Obstructive Pulmonary Disease Trial Network, Denmark 78 participants Est. completion 2020-05-09 1 site
    Other conditions: Adrenal Insufficiency
    View official trial listing →
  • Withdrawn NCT NCT03192969

    A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)

    Not yet reported Bristol-Myers Squibb Est. completion 2021-11-23 99 sites Stand-alone
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Completed NCT NCT03263715

    A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

    Not yet reported Medical University of Vienna 39 participants Est. completion 2020-06-02 3 sites Stand-alone
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Completed NCT NCT03266146

    36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

    Not yet reported, Not yet reported Beijing 302 Hospital 90 participants Est. completion 2023-01-31 1 site Stand-alone
    Other conditions: Drug-induced Liver Injury,Chronic
    View official trial listing →
  • Completed NCT NCT03291457

    A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice

    Hoffmann-La Roche 101 participants Est. completion 2019-12-04 22 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03920722

    Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

    Not yet reported Assistance Publique - Hôpitaux de Paris 8 participants Est. completion 2023-09-06 1 site Stand-alone
    Other conditions: Microscopic Polyangiitis (MPA)
    View official trial listing →
  • Status unknown NCT NCT04710849

    Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in AECOPD

    Peking University Third Hospital 100 participants Est. completion 2024-06-01 1 site
    Other conditions: COPD, COPD Exacerbation Acute
    View official trial listing →
  • Terminated NCT NCT04972968

    A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

    Not yet reported AbbVie 181 participants Est. completion 2023-07-24 117 sites
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Status unknown NCT NCT05138029

    Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

    Not yet reported Affiliated Hospital of Nantong University 60 participants Est. completion 2024-05 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Status unknown NCT NCT05292456

    Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc

    Hacettepe University 200 participants Est. completion 2022-12 1 site
    Other conditions: Glucocorticoids Toxicity, Rheumatoid Arthritis, Vasculitis, Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05525065

    Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)

    Premier Specialists, Australia 138 participants Est. completion 2025-09-01 1 site
    Other conditions: Autoimmune Bullous Dermatosis, Glucocorticoids Toxicity
    View official trial listing →
  • Completed NCT NCT05681676

    Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients

    Aalborg University 9 participants Est. completion 2022-12-01
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Status unknown NCT NCT06076824

    Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).

    Not yet reported Hospital General Universitario de Alicante 100 participants Est. completion 2024-09-01 1 site Stand-alone
    Other conditions: Heart Block, Aortic Stenosis, Bundle-Branch Block
    View official trial listing →
  • Enrolling by invitation NCT NCT06270719

    An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy

    Sarepta Therapeutics, Inc. 500 participants Est. completion 2038-12-31 29 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT06552442

    Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI

    Not yet reported Amosov National Institute of Cardiovascular Surgery 10 participants Est. completion 2024-06-01 1 site
    Other conditions: Ischemia-reperfusion Injury, No-reflow
    View official trial listing →
  • Not yet recruiting NCT NCT07639931

    Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application

    Not yet reported Tibet Autonomous Region People's Hospital 3035 participants Est. completion 2028-12-31 1 site
    Other conditions: Severe High Altitude Pulmonary Edema, Severe High Altitude Cerebral Edema
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Glucocorticoid treatment, prednis(ol)one, methylprednisolone

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.